KF af 1. november 2023 ApS: Financial statements 2017
CVR: 15278692
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
KF af 1. november 2023 ApS (CVR 15278692) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 268,997 and a net result of DKK 86,442 compared with DKK 325,502 the year before. That is a decrease of 59.5% compared with the year before. Equity in the 2017 report amounted to DKK 986,900. The solvency ratio was 85.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 268,997
- Profit/Loss
- DKK 86,442
- Equity
- DKK 986,900
- Total Assets
- DKK 1,155,393
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 269K | 86K | 987K | 1 |
| 2016 | - | 664K | 326K | 1.3M | 1 |
| 2015 | - | 646K | 306K | 1.3M | - |
| 2014 | - | 783K | 409K | 1.6M | 1 |
| 2013 | - | 700K | 371K | 1.5M | 1 |
Official annual report
Keep an eye on KF af 1. november 2023 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
KEMIFARMA ApS has published its annual report for 2016. Gross profit came to DKK 663,616, and the net result was DKK 325,502.
About KF af 1. november 2023 ApS
KF af 1. november 2023 ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, reopened in 2024. The company has been dissolved on 16 December 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2023). In 2022, the company reported a gross profit of DKK 300,304 and a net result of DKK 41,288 compared with DKK 243,538 the year before. Equity in the 2022 report amounted to DKK 638,454.
